Hassabis's Isomorphic Labs in talks to raise at ~$50 billion valuation
ns123abc · x · 2026-10-08
Scoop: Isomorphic Labs, Demis Hassabis's AI drug-discovery company, is in talks to raise new funding at roughly a $50 billion valuation, with the mission of solving all disease — up from the $40B+ valuation Bloomberg first reported.
Related event: Isomorphic Labs in Talks for Funding at Up to $50 Billion Valuation(5 posts)→
More from Venture
- Why assume open-weight model providers will stay open forever? — Atlan_ · 2026-10-08
- Indie dev's traffic flatlined for 9 days — the code was never pushed live — sujingshen · 2026-10-08
- Firmus, valued near $44bn, may shelve ASX IPO as investors balk — nordicinst · 2026-10-08
- Reverse AI Search Optimization: brands you just bought from vanish from ChatGPT recommendations — gaganghotra_ · 2026-10-08
- Going global: don't hire overseas staff before $2M ARR, use channel partners instead — sujingshen · 2026-10-08
- "Everyone's talking about selling data, but no one's talking about selling skills" — tedddyoweh · 2026-10-08